EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Poly Ethylene Glycol (PEG)‐Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review

Zihan Wang, Qinzhou Ye, Sheng Yu, Behnam Akhavan iD

Advanced Healthcare Materials · 2023-07 · 12 (18)

DOI: 10.1002/adhm.202300105 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023-05. Verfasst von Zihan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Nankai University, Tianjin, 300071, P. R. China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Hydrogels, Neoplasms, Polyethylene Glycols. Die Arbeit wurde bisher 206-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Hunter Medical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydrogel‐based drug delivery systems (DDSs) can leverage therapeutically beneficial outcomes in cancer therapy. In this domain, polyethylene glycol (PEG) has become increasingly popular as a biomedical polymer and has found clinical use. Owing to their excellent biocompatibility, facile modifiability, and high drug encapsulation rate, PEG hydrogels have shown great promise as drug delivery platforms. Here, the progress in emerging novel designs of PEG‐hydrogels as DDSs for anti‐cancer therapy is reviewed and discussed, focusing on underpinning multiscale release mechanisms categorized under stimuli‐responsive and non‐responsive drug release. The responsive drug delivery approaches are discussed, and the underpinning release mechanisms are elucidated, covering the systems functioning based on either exogenous stimuli‐response, such as photo‐ and magnetic‐sensitive PEG hydrogels, or endogenous stimuli‐response, such as enzyme‐, pH‐, reduction‐, and temperature‐sensitive PEG hydrogels. Special attention is paid to the commercial potential of PEG‐based hydrogels in cancer therapy, highlighting the limitations that need to be addressed in future research for their clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsHydrogelsNeoplasmsPolyethylene GlycolsBiocompatible MaterialsPolymersHumans

Stichwörter der Autor:innen

PEGcancerdrug delivery systemhydrogelsstimuli-responsiveness

Substanzen

Biocompatible MaterialsHydrogelsPolyethylene GlycolsPolymers

Autor:innen und Institutionen

  • College of Chemistry, Nankai University, Tianjin, 300071, P. R. China.
  • Sichuan Agricultural University, Sichuan, 611130, P. R. China.
  • Chemical Synthesis and Pollution Control Key Laboratory of Sichuan Province, China West Normal University, Nanchong, 637000, P. R. China.
  • School of Engineering, University of Newcastle, Callaghan, NSW, 2308, Australia.
  • Hunter Medical Research Institute (HMRI), New Lambton Heights, NSW, 2305, Australia.
  • School of Physics, The University of Sydney, Sydney, NSW, 2006, Australia.

ORCID-Profile: Behnam Akhavan

Förderung

  • Australian Research Council
  • Hunter Medical Research Institute

Zitieren

APA

Wang, Z., Ye, Q., Yu, S., & Akhavan, B. (2023). Poly Ethylene Glycol (PEG)‐Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review. Advanced Healthcare Materials, 12(18). https://doi.org/10.1002/adhm.202300105

Vancouver

Wang Z, Ye Q, Yu S, Akhavan B. Poly Ethylene Glycol (PEG)‐Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review. Advanced Healthcare Materials. 2023;12(18). doi:10.1002/adhm.202300105

BibTeX
@article{Wang2023,
  author = {Wang, Zihan and Ye, Qinzhou and Yu, Sheng and Akhavan, Behnam},
  title = {Poly Ethylene Glycol (PEG)‐Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {18},
  doi = {10.1002/adhm.202300105}
}
Kostenlos starten →